Lin28: an Emerging Important Oncogene Connecting Several Aspects of Cancer

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2016 Jan 15

PMID 26762415

Citations 15

Authors

Hao Wang

Qin Zhao

Kaiyuan Deng

Xiaoqiang Guo

Jiazeng Xia

Affiliations

Soon will be listed here.

Abstract

RNA-binding protein Lin28 was originally found as a heterochronic gene which played a significant role in the development of Caenorhabditis elegans. The tumor suppressor let-7 is a downstream target of Lin28, which has a wide variety of target genes which are involved in many aspects of cellular activities. By inhibition of let-7 and directly binding the target RNAs, Lin28 plays an important role in different biological and pathological processes including differentiation, metabolism, proliferation, pluripotency, and tumorigenesis. Overexpression of Lin28 has been reported in several kinds of cancers and is correlated with poor outcomes. It has been shown that Lin28 could affect the progression of cancers in several ways, such as promoting proliferation, increasing glucose metabolism, and inducing epithelial-mesenchymal transition (EMT) and cancer stem cells. Decrease of Lin28 expression or reactivation of let-7 in cancer cells could induce a reverse effect, indicating their therapeutic values in developing novel strategies for cancer treatment. Here, we will overview the regulatory mechanisms and functions of Lin28 in cancers.

Citing Articles

Nephron-Specific Overexpression Triggers Severe Inflammatory Response and Kidney Damage.

Futorian A, Armon L, Waldman Ben-Asher H, Shoval I, Hazut I, Munitz A Int J Biol Sci. 2024; 20(10):4044-4054.

PMID: 39113694 PMC: 11302891. DOI: 10.7150/ijbs.97434.

Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy.

Klinkovskij A, Shepelev M, Isaakyan Y, Aniskin D, Ulasov I Biomedicines. 2023; 11(12).

PMID: 38137554 PMC: 10741756. DOI: 10.3390/biomedicines11123333.

Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy.

Li J, Xiao Y, Yu H, Jin X, Fan S, Liu W Front Oncol. 2023; 13:1140133.

PMID: 37124491 PMC: 10130400. DOI: 10.3389/fonc.2023.1140133.

LIN28B Enhanced STAT3 Signaling Regulates Inflammatory Response and Chemotherapeutic Resistance in Cholangiocytes.

Puthdee N, Khramchantuk S, Nuwongsri P Asian Pac J Cancer Prev. 2021; 22(11):3671-3678.

PMID: 34837926 PMC: 9068185. DOI: 10.31557/APJCP.2021.22.11.3671.

The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma.

Puthdee N, Sriswasdi S, Pisitkun T, Ratanasirintrawoot S, Israsena N, Tangkijvanich P Cancer Gene Ther. 2021; 29(5):445-455.

PMID: 34548635 PMC: 9113936. DOI: 10.1038/s41417-021-00387-5.

References

Wang L, Zhang L, Wu J, Xu S, Xu Y, Li D . IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. Cancer Res. 2014; 74(17):4720-30. DOI: 10.1158/0008-5472.CAN-14-0960. View

Li Y, VandenBoom 2nd T, Kong D, Wang Z, Ali S, Philip P . Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009; 69(16):6704-12. PMC: 2727571. DOI: 10.1158/0008-5472.CAN-09-1298. View

Hu Q, Peng J, Liu W, He X, Cui L, Chen X . Lin28B is a novel prognostic marker in gastric adenocarcinoma. Int J Clin Exp Pathol. 2014; 7(8):5083-92. PMC: 4152071. View

Li N, Zhong X, Lin X, Guo J, Zou L, Tanyi J . Lin-28 homologue A (LIN28A) promotes cell cycle progression via regulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A (CDC25A) expression in cancer. J Biol Chem. 2012; 287(21):17386-17397. PMC: 3366838. DOI: 10.1074/jbc.M111.321158. View

Wilbert M, Huelga S, Kapeli K, Stark T, Liang T, Chen S . LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol Cell. 2012; 48(2):195-206. PMC: 3483422. DOI: 10.1016/j.molcel.2012.08.004. View

Oh J, Kim J, Byun J, Kim I . Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys. 2009; 76(1):5-8. DOI: 10.1016/j.ijrobp.2009.08.028. View

Biddle A, Mackenzie I . Cancer stem cells and EMT in carcinoma. Cancer Metastasis Rev. 2012; . DOI: 10.1007/s10555-012-9345-0. View

Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl E, Nitsch R . A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol. 2008; 10(8):987-93. DOI: 10.1038/ncb1759. View

Chien C, Wang M, Chu P, Chang Y, Liu W, Yu C . Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State. Cancer Res. 2015; 75(12):2553-65. DOI: 10.1158/0008-5472.CAN-14-2215. View

10.

Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A . RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-47. DOI: 10.1016/j.cell.2005.01.014. View

11.

Xu B, Zhang K, Huang Y . Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells. RNA. 2009; 15(3):357-61. PMC: 2657009. DOI: 10.1261/rna.1368009. View

12.

Lee Y, Dutta A . The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007; 21(9):1025-30. PMC: 1855228. DOI: 10.1101/gad.1540407. View

13.

Qin R, Zhou J, Chen C, Xu T, Yan Y, Ma Y . LIN28 is involved in glioma carcinogenesis and predicts outcomes of glioblastoma multiforme patients. PLoS One. 2014; 9(1):e86446. PMC: 3901701. DOI: 10.1371/journal.pone.0086446. View

14.

Nguyen L, Robinton D, Seligson M, Wu L, Li L, Rakheja D . Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell. 2014; 26(2):248-61. PMC: 4145706. DOI: 10.1016/j.ccr.2014.06.018. View

15.

Moss E, Lee R, Ambros V . The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell. 1997; 88(5):637-46. DOI: 10.1016/s0092-8674(00)81906-6. View

16.

Pallante P, Sepe R, Puca F, Fusco A . High mobility group a proteins as tumor markers. Front Med (Lausanne). 2015; 2:15. PMC: 4373383. DOI: 10.3389/fmed.2015.00015. View

17.

Lv K, Liu L, Wang L, Yu J, Liu X, Cheng Y . Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. PLoS One. 2012; 7(7):e40008. PMC: 3392258. DOI: 10.1371/journal.pone.0040008. View

18.

Zhu H, Shyh-Chang N, V Segre A, Shinoda G, Shah S, Einhorn W . The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011; 147(1):81-94. PMC: 3353524. DOI: 10.1016/j.cell.2011.08.033. View

19.

Piskounova E, Polytarchou C, Thornton J, LaPierre R, Pothoulakis C, Hagan J . Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell. 2011; 147(5):1066-79. PMC: 3227872. DOI: 10.1016/j.cell.2011.10.039. View

20.

Heo I, Joo C, Kim Y, Ha M, Yoon M, Cho J . TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell. 2009; 138(4):696-708. DOI: 10.1016/j.cell.2009.08.002. View